Abstract
In this paper we report the synthesis and in vitro activity of two new mixed ligand platinum complexes: trans- [PtCl2(thiazole)(imidazole) [JH3] and trans-[PtCl2(thiazole)(3-hydroxypyridine) [JH4]. Although the compounds are less active than cisplatin against the parent ovarian cancer cell line A2780, they are more active than cisplatin against the resistant cell lines A2780cisR and A2780ZD0473R, thus indicating that JH3 and JH4 have been better able to overcome mechanisms of resistance operating in A2780cisR and A2780ZD0473R. When Pt-DNA binding levels at 24 h in A2780, A2780cisR and A2780ZD0473R cell lines are compared it is found that whereas for cisplatin the values in resistant cell lines are significantly lower than that in the parent cell line, for JH3 and JH4 Pt-DNA binding levels in the parent and resistant cell lines are comparable, thus providing an explanation for variations in activity of the compounds in the three cell lines.
Keywords: Transplatinum, ovarian cancer, drug resistance, pBR322, plasmid, Pt-DNA binding, Mixed Ligand Platinum Compounds, numerous toxic side effects, trans-planaramineplatinum complexes, 3-diaminopyridine, imidazole, JETQUICK, K2PtCl4, tetrachloroplatinate, Microanalyses, trans-planaramineplatinum(II), Molar Conductivities, KBr beamsplitter, electrospray ionization, Cytotoxicity Assays, diphenyltetrazolium bromide, quadruplicate determinations, trypsinized, Proteinase, spectrophotometry, electrophoresis, phosphodiester, resistance factors, Accumulation of Pt, cisplatin in 2, 4, trans-platinum compounds, DNA Binding, Cisplatin, monofunctional adducts, piperidine, Enzyme Digestion, pBR322 plasmid DNA
Medicinal Chemistry
Title: Studies on Two New Mixed Ligand Platinum Compounds with a Trans- Geometry
Volume: 6 Issue: 5
Author(s): Jehad Al-Shuneigat, Jun Qing Yu, Philip Beale, Keith Fisher and Fazlul Huq
Affiliation:
Keywords: Transplatinum, ovarian cancer, drug resistance, pBR322, plasmid, Pt-DNA binding, Mixed Ligand Platinum Compounds, numerous toxic side effects, trans-planaramineplatinum complexes, 3-diaminopyridine, imidazole, JETQUICK, K2PtCl4, tetrachloroplatinate, Microanalyses, trans-planaramineplatinum(II), Molar Conductivities, KBr beamsplitter, electrospray ionization, Cytotoxicity Assays, diphenyltetrazolium bromide, quadruplicate determinations, trypsinized, Proteinase, spectrophotometry, electrophoresis, phosphodiester, resistance factors, Accumulation of Pt, cisplatin in 2, 4, trans-platinum compounds, DNA Binding, Cisplatin, monofunctional adducts, piperidine, Enzyme Digestion, pBR322 plasmid DNA
Abstract: In this paper we report the synthesis and in vitro activity of two new mixed ligand platinum complexes: trans- [PtCl2(thiazole)(imidazole) [JH3] and trans-[PtCl2(thiazole)(3-hydroxypyridine) [JH4]. Although the compounds are less active than cisplatin against the parent ovarian cancer cell line A2780, they are more active than cisplatin against the resistant cell lines A2780cisR and A2780ZD0473R, thus indicating that JH3 and JH4 have been better able to overcome mechanisms of resistance operating in A2780cisR and A2780ZD0473R. When Pt-DNA binding levels at 24 h in A2780, A2780cisR and A2780ZD0473R cell lines are compared it is found that whereas for cisplatin the values in resistant cell lines are significantly lower than that in the parent cell line, for JH3 and JH4 Pt-DNA binding levels in the parent and resistant cell lines are comparable, thus providing an explanation for variations in activity of the compounds in the three cell lines.
Export Options
About this article
Cite this article as:
Al-Shuneigat Jehad, Qing Yu Jun, Beale Philip, Fisher Keith and Huq Fazlul, Studies on Two New Mixed Ligand Platinum Compounds with a Trans- Geometry, Medicinal Chemistry 2010; 6 (5) . https://dx.doi.org/10.2174/157340610793358837
DOI https://dx.doi.org/10.2174/157340610793358837 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Delta Np63 alpha – Responsive microRNA Modulate the Expression of Metabolic Enzymes
Current Pharmaceutical Biotechnology Functional Characteristic of Snake Venom Disintegrins: Potential Therapeutic Implication
Current Pharmaceutical Design The Synergistic Effect of Humanized Monoclonal Antibodies Targeting Insulin-Like Growth Factor 1 Receptor (IGF-1R) and Chemotherapy
Current Drug Targets Exploring the Role of Phytochemicals as Potent Natural Photosensitizers in Photodynamic Therapy
Anti-Cancer Agents in Medicinal Chemistry PRL-3, An Emerging Marker of Carcinogenesis, Is Strongly Associated with Poor Prognosis
Anti-Cancer Agents in Medicinal Chemistry Current Dendrimer Applications in Cancer Diagnosis and Therapy
Current Topics in Medicinal Chemistry Intracellular Calcium Homeostasis and Kidney Disease
Current Medicinal Chemistry Bilski: Assessing the Impact of a Newly Invigorated Patent-Eligibility Doctrine on the Pharmaceutical Industry and the Future of Personalized Medicine
Current Topics in Medicinal Chemistry Editorial: (Thematic Issue: Nanofluidics and Microfluidics: Novel Approaches in Biomedical Science)
Current Proteomics Pharmacogenetics of Irinotecan Disposition and Toxicity: A Review
Current Clinical Pharmacology Nucleosides with Modified Sugar Ring: Synthesis and Biological Activities
Current Organic Chemistry Doxycycline in Mitochondrial Mediated Pathway of Apoptosis: A Systematic Review
Anti-Cancer Agents in Medicinal Chemistry Increased Expression of the Remodeling- and Tumorigenic-Associated Factor Osteopontin in Pyramidal Neurons of the Alzheimers Disease Brain
Current Alzheimer Research CDKN2B-AS1: An Indispensable Long Non-coding RNA in Multiple Diseases
Current Pharmaceutical Design Advanced Biomedical Techniques for Gene Delivery
Recent Patents on Biomedical Engineering (Discontinued) An Emerging Strategy for Cancer Treatment Targeting Aberrant Glycogen Synthase Kinase 3β
Anti-Cancer Agents in Medicinal Chemistry Polyphenols: Biological Activities, Molecular Targets, and the Effect of Methylation
Current Molecular Pharmacology Targeting Sphingosine-1-Phosphate Receptors in Cancer
Anti-Cancer Agents in Medicinal Chemistry Radioprotection of Normal Tissue to Improve Radiotherapy: The Effect of the Bowman Birk Protease Inhibitor
Current Medicinal Chemistry - Anti-Cancer Agents Cigarette Smoking, Metabolic Activation and Carcinogenesis
Current Drug Metabolism